Aurora Cannabis Inc. - Common Shares (ACB)

President Trump's social media feed put the markets in a frenzy.

U.S. markets kicked off the week quietly, but certain stocks were anything but dull. Cannabis names surged after a Trump-endorsed CBD video went viral, while biotech firm MoonLake was crushed by disastrous trial results. Meanwhile, macro tension builds with a potential U.S. government shutdown and Friday’s key jobs report looming.

President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.

Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.

Aurora Cannabis Q1 FY26 earnings call transcript

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

The company also clarified it holds no material non-public information as it begins an internal probe into the source of the reports.

Aurora's CEO defends partnership with PMI-owned Aspeya, saying it's about science, not Big Tobacco. Here's what we learned.

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.